Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by Vinva Investment Management Ltd

Vinva Investment Management Ltd raised its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 10.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,564 shares of the biotechnology company’s stock after acquiring an additional 346 shares during the quarter. Vinva Investment Management Ltd’s holdings in Axon Enterprise were worth $2,154,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in AXON. Natixis Advisors LLC raised its holdings in shares of Axon Enterprise by 5.4% in the third quarter. Natixis Advisors LLC now owns 30,392 shares of the biotechnology company’s stock worth $12,145,000 after acquiring an additional 1,552 shares during the last quarter. Fifth Third Wealth Advisors LLC raised its holdings in shares of Axon Enterprise by 35.4% in the third quarter. Fifth Third Wealth Advisors LLC now owns 1,082 shares of the biotechnology company’s stock worth $432,000 after acquiring an additional 283 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new position in shares of Axon Enterprise in the third quarter worth $2,162,000. PNC Financial Services Group Inc. raised its holdings in shares of Axon Enterprise by 17.5% in the third quarter. PNC Financial Services Group Inc. now owns 5,627 shares of the biotechnology company’s stock worth $2,249,000 after acquiring an additional 840 shares during the last quarter. Finally, Avior Wealth Management LLC raised its holdings in shares of Axon Enterprise by 3.0% in the third quarter. Avior Wealth Management LLC now owns 2,995 shares of the biotechnology company’s stock worth $1,197,000 after acquiring an additional 86 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $558.41 on Friday. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The business has a 50-day moving average of $592.10 and a 200-day moving average of $539.60. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $42.79 billion, a price-to-earnings ratio of 144.29, a PEG ratio of 5.17 and a beta of 1.12.

Insider Transactions at Axon Enterprise

In other news, Director Jeri Williams sold 307 shares of the company’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 1,035 shares of the company’s stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the sale, the insider now directly owns 124,243 shares of the company’s stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,792 shares of company stock valued at $1,087,843 over the last quarter. Company insiders own 5.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on AXON. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. TD Cowen began coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. Finally, Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $604.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.